Life Sciences Tools and Services
Company Overview of NABsys, Inc.
NABsys, Inc., a life sciences company, develops solid-state electronic systems for single-molecule DNA sequencing and analysis. It develops an electronic solid-state DNA sequencing platform that uses solid-state nanodetectors to analyze single DNA molecules by electronic detection, revealing location and identity of DNA sequences over long distances. The company develops its produts for genome research, cancer genomics, and AgBio applications. NABsys, Inc. was incorporated in 2004 and is based in Providence, Rhode Island.
60 Clifford Street
Providence, RI 02903
Founded in 2004
Key Executives for NABsys, Inc.
Chief Executive Officer, President and Director
Chairman of the Board and First Chief Commercial Officer
Co-Founder and Sab Member
Compensation as of Fiscal Year 2014.
NABsys, Inc. Key Developments
Nabsys and Ariana Pharma Collaborate to Identify DNA Structural Variants Linked to Targeted Cancers
Jan 12 15
Nabsys, Inc., and Ariana Pharmaceuticals SA, announced a collaboration that aims to identify sets of DNA structural variants linked to prostate and breast cancers and to the clinical outcome of patients with these diseases through the analysis of public genome databases. Through the partnership, the two companies will develop a single database each for the analysis of Prostate Adenocarcinomas and for the analysis of Breast Cancer. The generation of two signatures comprised of previously-identified DNA structure variations will improve individual predictive capabilities and will ultimately be employed in personalize treatment plans. The ability to demonstrate links between SVs and Progression Free Survival (PFS) and Overall Survival (OS) end-points goes well beyond the current commercial offerings for small segment sequencing.
NABsys, Inc. Appoints Anthony Shuber as Vice President and Chief Scientific Officer
Oct 27 14
NABsys, Inc. announced that Anthony Shuber has joined the company as Vice President and Chief Scientific Officer. In this role, Shuber will lead the company's efforts in product strategy as the company transitions its initial commercial focus toward oncology. Shuber, an industry veteran and accomplished inventor, has over 24 years of experience in developing commercial diagnostics and research and applied genomics products and holds 50 patents.
Nabsys Appoints Steve Lombardi as President and Chief Executive Officer
Sep 15 14
Nabsys, Inc. named Steve Lombardi as the company's President and Chief Executive Officer effective immediately. The company has also appointed Mr. Lombardi to its Board of Directors. Lombardi has been associated with the key technologies that have defined modern molecular biology and has been responsible for large and fast growing product lines in the life science tools industry. He has over 35 years of experience in life sciences as a scientist, product manager, general manager and CEO at Applied Biosystems, Affymetrix, Helicos BioSciences and Real Time Genomics. At Nabsys, Lombardi will be responsible for driving commercialization of its technology.
Similar Private Companies By Industry
Recent Private Companies Transactions
August 21, 2014